Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 18, 2007
The effects of ABCB1 3'-untranslated region variants on mRNA stability
Jason M Gow, Leslie W Chinn, Deanna L Kroetz
The Journal of Pharmacology and Experimental Therapeutics
|
February 22, 2008
Substrate-dependent effects of human ABCB1 coding polymorphisms
Jason M Gow, Laura M Hodges, Leslie W Chinn, et al.
The Journal of Antimicrobial Chemotherapy
|
May 19, 2007
Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein
Leslie W Chinn, Jason M Gow, Man Ming Tse, et al.
Pharmacogenetics and Genomics
|
March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)
Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
Arthritis Research & Therapy
|
October 10, 2015
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
Jason M Gow, Wayne H Tsuji, Gary J Williams, et al.
Protein Science : a Publication of the Protein Society
|
August 28, 2010
Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains
Libusha Kelly, Hisayo Fukushima, Rachel Karchin, et al.
Pharmacological Reviews
|
March 2, 2006
PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network
Tan D Nguyen, Jason M Gow, Leslie W Chinn, et al.
Plos One
|
September 11, 2009
Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation
Stephanie E Hesselson, Pär Matsson, James E Shima, et al.
British Journal of Clinical Pharmacology
|
May 8, 2014
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases
Wei-Jian Pan, Kathleen Köck, William A Rees, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 18, 2007
The effects of ABCB1 3'-untranslated region variants on mRNA stability
Jason M Gow, Leslie W Chinn, Deanna L Kroetz
The Journal of Pharmacology and Experimental Therapeutics
|
February 22, 2008
Substrate-dependent effects of human ABCB1 coding polymorphisms
Jason M Gow, Laura M Hodges, Leslie W Chinn, et al.
The Journal of Antimicrobial Chemotherapy
|
May 19, 2007
Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein
Leslie W Chinn, Jason M Gow, Man Ming Tse, et al.
Pharmacogenetics and Genomics
|
March 11, 2010
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)
Laura M Hodges, Svetlana M Markova, Leslie W Chinn, et al.
Arthritis Research & Therapy
|
October 10, 2015
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects
Jason M Gow, Wayne H Tsuji, Gary J Williams, et al.
Protein Science : a Publication of the Protein Society
|
August 28, 2010
Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains
Libusha Kelly, Hisayo Fukushima, Rachel Karchin, et al.
Pharmacological Reviews
|
March 2, 2006
PharmGKB submission update: IV. PMT submissions of genetic variations in ATP-Binding cassette transporters to the PharmGKB network
Tan D Nguyen, Jason M Gow, Leslie W Chinn, et al.
Plos One
|
September 11, 2009
Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation
Stephanie E Hesselson, Pär Matsson, James E Shima, et al.
British Journal of Clinical Pharmacology
|
May 8, 2014
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases
Wei-Jian Pan, Kathleen Köck, William A Rees, et al.
Page
of 1